• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝切除术后并发症的时间和严重程度及其与 30 天死亡率的关系:国家手术质量改进计划研究。

Timing and Severity of Postoperative Complications and Associated 30-Day Mortality Following Hepatic Resection: a National Surgical Quality Improvement Project Study.

机构信息

Department of Surgery, The Ohio State University Wexner Medical Center and James Cancer Hospital and Solove Research Institute, 395 W. 12th Ave., Suite, Columbus, OH, 670, USA.

出版信息

J Gastrointest Surg. 2022 Feb;26(2):314-322. doi: 10.1007/s11605-021-05088-w. Epub 2021 Aug 6.

DOI:10.1007/s11605-021-05088-w
PMID:34357529
Abstract

BACKGROUND

The effect of varying severity and timing of complications after hepatic resection on 30-day mortality has not been thoroughly examined.

METHODS

National Surgical Quality Improvement Program Patient User Files (NSQIP-PUF) were used to identify patients who underwent elective hepatic resection between 2014 and 2019. The impact of number, timing, and severity of complications on 30-day mortality was examined.

RESULTS

Among 25,084 patients who underwent hepatic resection, 7436 (29.9%) patients developed at least one NSQIP complication, while 2688 (10.7%) had multiple (≥2) complications. Overall, 30-day mortality was 1.7% (n=424), among whom 81.4% (n=345) patients had ≥2 complications. The 30-day mortality was highest among patients with three consecutive severe complications (47.8%), as well as patients with one non-severe and two subsequent severe complications (47.6%). The adjusted probability of 30-day mortality was 35.5% (95%CI: 29.5-41.4%) when multiple severe complications occurred within the first postoperative week and 16.2% (95%CI: 7.2-25.1%) when the second severe complication occurred at least one week apart. The adjusted risk of 30-day mortality after even two non-severe complications was as high as 5.3% (95%CI: 3.7-6.9%) when the second complication occurred within a week postoperatively.

CONCLUSION

Approximately 1 in 10 patients developed multiple complications following hepatectomy. Timing and severity of complications were independently associated with 30-day mortality.

摘要

背景

尚未彻底研究肝切除术后并发症严重程度和时间变化对 30 天死亡率的影响。

方法

使用国家手术质量改进计划患者用户档案(NSQIP-PUF)确定 2014 年至 2019 年间接受择期肝切除术的患者。检查并发症数量、时间和严重程度对 30 天死亡率的影响。

结果

在接受肝切除术的 25084 例患者中,7436 例(29.9%)患者至少发生了 1 项 NSQIP 并发症,而 2688 例(10.7%)患者发生了多种(≥2 种)并发症。总体而言,30 天死亡率为 1.7%(n=424),其中 81.4%(n=345)患者有≥2 种并发症。30 天死亡率最高的是连续发生 3 种严重并发症的患者(47.8%),以及有 1 种非严重并发症和随后发生的 2 种严重并发症的患者(47.6%)。当多个严重并发症在术后第一周内连续发生时,30 天死亡率的调整概率为 35.5%(95%CI:29.5-41.4%),当第二个严重并发症相隔至少一周发生时,调整后的 30 天死亡率为 16.2%(95%CI:7.2-25.1%)。即使发生了 2 次非严重并发症,当第二次并发症发生在术后一周内时,30 天死亡率的调整风险也高达 5.3%(95%CI:3.7-6.9%)。

结论

约每 10 例接受肝切除术的患者中就有 1 例发生了多种并发症。并发症的时间和严重程度与 30 天死亡率独立相关。

相似文献

1
Timing and Severity of Postoperative Complications and Associated 30-Day Mortality Following Hepatic Resection: a National Surgical Quality Improvement Project Study.肝切除术后并发症的时间和严重程度及其与 30 天死亡率的关系:国家手术质量改进计划研究。
J Gastrointest Surg. 2022 Feb;26(2):314-322. doi: 10.1007/s11605-021-05088-w. Epub 2021 Aug 6.
2
The impact of chronic liver disease on the risk assessment of ACS NSQIP morbidity and mortality after hepatic resection.慢性肝病对肝切除术后ACS NSQIP发病率和死亡率风险评估的影响。
Surgery. 2016 May;159(5):1308-15. doi: 10.1016/j.surg.2015.11.020. Epub 2015 Dec 31.
3
Blood transfusion is an independent predictor of morbidity and mortality after hepatectomy.输血是肝切除术后发病率和死亡率的独立预测因素。
J Surg Res. 2016 Nov;206(1):106-112. doi: 10.1016/j.jss.2016.07.013. Epub 2016 Jul 15.
4
Evaluation of the ACS NSQIP Surgical Risk Calculator in Elderly Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.评估 ACS NSQIP 手术风险计算器在老年肝细胞癌患者肝切除术中的应用。
J Gastrointest Surg. 2020 Mar;24(3):551-559. doi: 10.1007/s11605-019-04174-4. Epub 2019 Apr 1.
5
Preoperative Portal Vein Embolization Is Not Associated with Increased Postoperative Complications After Major Hepatectomy: a Study of the National Surgical Quality Improvement Database.术前门静脉栓塞与大肝切除术后术后并发症增加无关:国家手术质量改进数据库研究。
J Gastrointest Surg. 2020 Jul;24(7):1561-1570. doi: 10.1007/s11605-019-04313-x. Epub 2019 Jul 24.
6
Assessment of complications after liver surgery: Two novel grading systems applied to patients undergoing hepatectomy.肝切除术后并发症的评估:两种新型分级系统应用于接受肝切除术的患者。
J Huazhong Univ Sci Technolog Med Sci. 2017 Jun;37(3):352-356. doi: 10.1007/s11596-017-1739-3. Epub 2017 Jun 6.
7
Left hepatectomy combined with hepatic artery resection for hilar cholangiocarcinoma: A retrospective cohort study.左半肝切除术联合肝动脉切除治疗肝门部胆管癌:一项回顾性队列研究。
Int J Surg. 2016 Aug;32:167-73. doi: 10.1016/j.ijsu.2016.06.038. Epub 2016 Jun 23.
8
Complication timing impacts 30-d mortality after hepatectomy.并发症发生时间影响肝切除术后30天死亡率。
J Surg Res. 2016 Jun 15;203(2):495-506. doi: 10.1016/j.jss.2016.04.047. Epub 2016 Apr 27.
9
Thirty-Day Morbidity after Simultaneous Resection of Colorectal Cancer and Colorectal Liver Metastasis: American College of Surgeons NSQIP Analysis.结直肠癌和结直肠肝转移同时切除术后 30 天发病率:美国外科医师学院 NSQIP 分析。
J Am Coll Surg. 2020 Apr;230(4):617-627.e9. doi: 10.1016/j.jamcollsurg.2019.12.018. Epub 2020 Jan 30.
10
A Tool to Estimate Risk of 30-day Mortality and Complications After Hip Fracture Surgery: Accurate Enough for Some but Not All Purposes? A Study From the ACS-NSQIP Database.一种用于评估髋部骨折手术后 30 天死亡率和并发症风险的工具:对于某些目的足够准确,但并非所有目的都准确?来自 ACS-NSQIP 数据库的研究。
Clin Orthop Relat Res. 2022 Dec 1;480(12):2335-2346. doi: 10.1097/CORR.0000000000002294. Epub 2022 Jun 27.

引用本文的文献

1
Association of Viral Hepatitis Status and Post-hepatectomy Outcomes in the Era of Direct-Acting Antivirals.直接抗病毒药物时代病毒性肝炎状态与肝切除术后结局的关联
Ann Surg Oncol. 2023 May;30(5):2793-2802. doi: 10.1245/s10434-022-12937-8. Epub 2022 Dec 14.

本文引用的文献

1
Reducing surgical complications.减少手术并发症。
Jt Comm J Qual Patient Saf. 2007 Nov;33(11):660-5. doi: 10.1016/s1553-7250(07)33075-4.